Resultados de la búsqueda 851-860 of 6717 for Selective mutism

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Jacksonville, Fla. The purpose of this study is to explore the translational abilities of desorption electrospray ionization mass spectrometry (DESI-MS) as ...

  2. Oncología (médica) - Ensayos clínicos

    This protocol allows multiple treatments with TheraSphere® that may be delivered on an outpatient basis. Patients may receive a single dose to a liver lobe ...

  3. Oncología (médica) - Ensayos clínicos

    The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...

  4. Radiología - Ensayos clínicos

    The purpose of this pilot study is to analyze the effectiveness of a new ultrasound microvessel imaging technology for evaluation of synovitis in patients with ...

  5. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates ...

  6. Oncología (médica) - Ensayos clínicos

    For example, inflammatory bowel disease is a major predisposing factor for colorectal cancer occurrence, implicating inflammation in the development of ...

  7. Enfermedades alérgicas - Ensayos clínicos - Mayo Clinic

    The primary objective of this study is to investigate the contribution of group 2 innate lymphoid cells (ILC2s) to the immunologic mechanisms of chronic airway ...

  8. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to develop patient-derived organoid cultures of urothelial carcinoma from non-invasively obtained urine samples ...

  9. Apraxia del habla infantil - Síntomas y causas - Mayo Clinic

    Este trastorno del habla se presenta cuando el cerebro no se comunica correctamente con los músculos utilizados para hablar. La terapia del habla puede ...

  10. Oncología (médica) - Ensayos clínicos

    Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...